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Telomeres are specialized DNA-protein structures at the ends of the linear chromosomes. In mammalian cells, they
are composed of multifold hexameric TTAGGG repeats and a number of associated proteins. The double-stranded
telomeric DNA ends in a 30 single stranded overhang of 150 to 300 base pair (bp) which is believed to be required for
a higher order structure (reviewed in (Blackburn, 2001)). One important model is that the telomeres form loop
structures, the T-loops, and by invasion of the 30 overhang into the duplex region of the double stranded part
protect the DNA against degradation and hinder the cellular machinery to recognize the ends as broken DNA, thus
providing chromosomal integrity (Grifﬁth et al, 1999). If telomeres become critically short they loose their capping
function, become sticky, and are prone to illegitimate chromosome end-to-end fusions. The resulting dicentric
chromosomes are highly unusable and because of bridge-fusion-breakage cycles they give rise to chromosomal
translocations, deletions, and ampliﬁcations. Thus, critically short telomeres are thought to be responsible for the
onset of genomic instability. In addition, we provide evidence that in a length-independent manner telomeres
can confer to genomic instability by forming telomeric aggregates which through chromosomal dys-locations
contribute to chromosomal aberrations.
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Telomere Shortening During Cellular Aging
During proliferation of normal human somatic cells, telo-
mere length progressively shortens and the cells finally
arrest in a stage called replicative senescence. This
termination of growth, also defined as the Hayflick (1965)
limit, is now believed to be a consequence of one or a few
critically short telomeres resulting from the continuous rep-
lication-dependent telomere erosion and triggering a signal
cascade that causes a damage-dependent irreversible
growth arrest (for a review, see Wright and Shay, 2002).
This telomere shortening is a consequence of the so-called
end replication problem. As shown by Olovnikov (1973) and
Watson (1972), DNA polymerase a is not able to replicate
the lagging strand DNA up to the outermost end and there-
fore with each replication cycle, a number of bp of telomeric
DNA are lost. In addition, oxidative damage adds to telo-
mere shortening (Saretzki and von Zglinicki, 2002), causing
a 50–200 bp loss per cell generation. This continuous telo-
mere loss is now thought to be the ‘‘mitotic clock’’ of cellular
aging (Harley, 1991).
It was found that the stage of critically short telomeres
correlated with a great number of telomeric end-to-end fu-
sions, thus giving rise to dicentric chromosomes (reviewed
in Mathieu et al, 2004). Nevertheless, it is still a matter of
debate as to whether the stage of instable chromosomes is
related to the onset of senescence, also called mortality
stage 1, or requires additionally forced proliferation leading
to additional telomere erosion with a mean final length sig-
nificantly shorter than at senescence. At this second state,
mortality stage 2, the cells enter crisis and most cells die
(reviewed in Shay and Wright, 2005). Our studies did not
provide evidence for a senescence-dependent chromo-
somal instability, either in human aging fibroblasts (Figueroa
et al, 2000) or in human skin keratinocytes.1 But we ob-
served an increased number of abnormal chromosomes
shortly after trypsinization of the cells, which disappeared
again few days after passaging. We presently cannot ex-
clude that the fragility of the chromosomes increases with
aging, and that therefore the high frequency of aberrations
determined by Benn (1976) one day after plating of the se-




Ducray et al (1999), on the other hand, analyzed SV-40-
transfected cells, thereby overcoming the normal process
leading to cellular senescence (M1) and studying changes
related to the phase of prolonged growth, i.e., occurring
between the M1 and M2 phase. When the replicative po-
tential is extended either spontaneously or due to introduc-
tion of viral oncogenes (e.g., SV-40 or HPV), telomeres
Abbreviations: BFB, Bridge-Fusion-Breakage; TA, telomeric aggre-
grates, TRF2, telomere repeat binding factor 2 1Peter and Boukamp, unpublished observations.
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continue to shorten. In agreement with telomeres becoming
critically short, a high frequency of chromosome abnormal-
ities were detected (Ducray et al, 1999). Accordingly, stud-
ies with telomerase-deficient mice had shown that in late-
generation mice where the originally long telomeres (mean
telomere length of about 50 kb) had finally shortened to a
length similar to human telomeres, end-to-end chromo-
somal fusions were the most prominent aberrations (Blasco
et al, 1997). Since chromosomes with the shortest telo-
meres were frequently involved, this also argued for
critically short and therefore unprotected telomeres to be
causal for the end-to-end fusions (Hemann et al, 2001).
Uncapping of the telomeres by overexpressing a dominant-
negative version of the a protein known to be involved in
protecting the T-loop structure, the telomere repeat binding
factor 2 (TRF2), finally demonstrated that it is not neces-
sarily the shortest telomere. Instead, loss of the capping
function of the telomeres resulted in chromosomal end-to-
end fusions and with that in the formation of dicentric chro-
mosomes (van Steensel et al, 1998).
It is now commonly discussed that this scenario, crit-
ically short telomeres forming dicentric chromosomes, is a
first step of telomere length-dependent genomic instability
(reviewed in Murnane and Sabatier, 2004). Dicentric chro-
mosomes are highly unstable. If both centromeres are ac-
tive during mitosis, each centromere may attach to a
different pole, thus forming an anaphase bridge when the
chromosomes are torn apart. As a result of this bipolar
tension, breakage can occur all along the fused chromo-
somes. Thus, anaphase bridges are often viewed as a sign of
genomic instability. Depending on whether both parts con-
tain a centromere, this can easily result in loss of part of the
chromosomes. In addition, and as extensively discussed by
Murnane and Sabatier (2004), this can also lead to amplifi-
cation cycles of certain chromosome parts. On the other
hand, the telomere-free and highly recombinant DNA ends
may invade other chromosomes, perhaps based on areas of
micro-homology, and thereby causing non-reciprocal trans-
locations. All this led to the proposal of a fusion-bridge-
breakage cycle, also known as Bridge-Fusion-Breakage
(BFB) model, as a primary mechanism of genomic instabil-
ity in cells that suffer from critically short telomeres (reviewed
in Chang et al, 2001; Mathieu et al, 2004). This BFB, which
was first described by McClintock (1941), for Zea mays is
now extensively used to explain the various translocation
chromosomes found in tumor cells.
Additional Models of Telomere-Dependent
Genomic Instability
Alternatively, Greider and co-workers suggest that end-to-
end chromosome fusions may not initiate rearrangements
but may rather be a secondary effect of end resection and
thus represent stable by-products. Studying chromosomal
rearrangements in diploid yeast strains, they found that
chromosomal rearrangements predominantly occurred in
the terminal region of the chromosome where exonuclease
(Exo1p) had eliminated the telomere and allowed end-to-
end fusions to occur (Hackett and Greider, 2003). Genes
inserted at the ends of the chromosomes were eliminated
in a non-random fashion in Exo1p efficient yeast strains,
whereas there were fewer chromosome rearrangements in
yeast strains missing Exo1p. From this, they concluded that
Exo1p plays a major role in the generation of these rear-
rangements and that end resection initiates genomic insta-
bility at dysfunctional telomeres (Hackett and Greider,
2003).
Along this line, Weinberg and co-workers propose that it
is not the overall telomere length (critically short telomere)
but loss of the single-strand overhang that is crucial, and
that telomerase plays an important role in maintaining the 30
overhang (Stewart et al, 2003). Thus, it still remains to be
resolved as to which of these changes will be most impor-
tant in causing genomic instability. It also cannot be ex-
cluded at present that different mechanisms may act
together and thereby give rise to the different kinds of
translocation chromosomes either maintaining or lacking
intrachromosomal telomeres (Fig 1).
Telomere Length-Dependent Genomic
Instability a Continuous Process?
Critically short and unprotected telomeres are supposed to
be an initial event of genomic instability in cells lacking tel-
omerase activity and, therefore, loss of capping function
can be viewed as an early stage in the transformation proc-
ess from normal to tumor cells. Furthermore, it is suggested
that the fusions generated by the first BFB cycle could
generate new unstable chromosomes, perpetuating the
BFB cycle and chromosomal instability until no more open
ends are available (extensively reviewed in Murnane and
Sabatier, 2004). This implies that genomic instability in-




Once telomerase is upregulated, the telomeres should be
stabilized and tumor cells should be protected against
‘‘telomere length-dependent’’ genomic instability. Neverthe-
less, immortal and tumor cells are similarly prone to gen-
Figure1
Translocation chromosomes with and without inter-chromosomal
telomeres. As a result of the Fusion-Bridge-Breakage cycle, translo-
cation chromosomes can establish which, on the one hand, are derived
by telomeric fusion and still maintain telomeric sequences. On the other
hand, the dicentric chromosomes can break and rejoin at non-tel-
omeric sequences, giving rise to a translocation chromosome without
intra-chromosomal telomeric sequences.
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omic instability. Interestingly, our observations indicate that
immortal and tumor cells that exhibit a near-diploid karyo-
type are genetically rather stable. HaCaT skin keratinocytes
immortalized spontaneously and selected for maintaining a
pseudodiploid karyotype hardly showed any new chromo-
somal aberrations as measured by comparative genomic
hybridization or multicolor fluorescence in situ hybridization
(Boukamp et al, 19972) (Fig 2). The primary karyotypic
alterations established with immortalization were stablely
maintained over many passages in culture. Once polyp-
loidization had occurred, the cells were prone to a contin-
uous, although low level of changes, thereby favoring
the development of genetically divergent subpopulations
(Boukamp et al, 1997).
These changes occurred in cells that were able to coun-
teract telomere erosion by expressing the ribonucleoprotein
complex telomerase (Greider and Blackburn, 1985). Telom-
erase is able to use its RNA component (in the human cells:
hTR) to anchor to the outermost end of the telomere and to
act as a template for the catalytic subunit hTERT, which
synthesizes telomeric DNA, thus compensating for the rep-
lication-dependent telomere loss. In early studies, telomerase
activity could only be detected in germ line cells and tumor
cells, whereas it was absent in normal somatic cells (Kim
et al, 1994). In the meantime, however, it is well established
that normal regenerative tissues also express telomerase
activity, although at a generally lower level than immortal cells
or tumor cells (summarized in Bachor et al, 1999). Although it
is still a matter of debate whether the level of telomerase
activity is sufficient for maintaining telomere length or at least
minimizing telomere erosion (Shay and Wright, 2005), our re-
cent experiments suggest that in the epidermis, telomerase
activity is not only present but may also be functionally im-
portant (Harle-Bachor and Boukamp, 1996).3
Telomerase expression by infection or transfection of
hTERT, the limiting component of the telomerase complex,
has been shown to prevent telomere shortening and to ex-
tend the life span of the normal cells for a variety of normal
cells, thus being essential for indefinite cell growth (Bodnar
et al, 1998; for a review, see Tominaga et al, 2002). hTERT-
infected cells, however, often differ from those cells that
have upregulated endogenous telomerase during tumor
progression. Generally, telomerase causes a dynamic bal-
ance between telomere loss and telomere elongation, which
results in a net telomere stabilization and length homoge-
nization. hTERT infection or transfection often correlates
with significant telomere elongation (Cerezo et al, 2003;
Swiggers et al, 2004). In addition, evidence is increasing
that upon exogeneous hTERT overexpression, telomerase
exerts additional non-telomeric functions including changes
in growth potential (Wang et al, 1998; Mondello et al, 2003),
differentiation (Cerezo et al, 2003), induction of a pre-
malignant phenotype (Milyavsky et al, 2003), and even in-
creased tumorigenic potential in mice (Artandi et al, 2002;
Gonzalez-Suarez et al, 2002). Different from early reports
that highlighted the phenotypic and genotypic integrity of
hTERT-dependent cell immortalization (Morales et al, 1999),
the role of telomerase is now being explored more broadly.
So far, it is still not known as to what causes the additional
telomerase effect. It thus remains to be determined whether
these extra activities are a consequence of high levels of
hTERT itself, an unusually high level of telomerase activity,
or due to the fact that hTERT is no longer under the control
of cell growth and differentiation-specific regulations.
Insults Causing Genomic Instability in
Telomerase-Positive Cells
Genomic instability cannot always be explained by the fact
that once it occurs, it is transmitted to daughter cells and
is self-perpetuating. Instead, other mechanisms are likely to
contribute to genomic instability as well. One mechanism
that is frequently discussed is centrosome duplication. Car-
roll et al (1999) suggested that p53 mutations as well as
MDM2 overexpression, induced aneuploidy through cent-
rosome amplification. Similarly, Munger and co-workers
provided evidence that HPV-induced genomic instability
is in part mediated through centrosome amplification (re-
viewed in Duensing and Munger, 2004). It has long been
known that HPV-16 E6 can cause structural chromosomal
changes (White et al, 1994), whereas E7 is responsible
for aneuploidy (Hashida and Yasumoto, 1991; White et al,
1994). Correspondingly, they showed that E7 is responsible
for abnormal centrosome synthesis (Duensing et al, 2001),
and that E6 and E7 cooperated in inducing genomic insta-
bility by uncoupling centrosome duplication from cell divi-
sion (Duensing et al, 2000).
Similar to HPV, c-Myc deregulation is also thought to
induce genomic instability and centrosome duplication may
be one potential mechanism (Mai and Mushinski, 2003).
Evidence is increasing that an important consequence of
deregulated c-myc expression is the induction of gene am-
plification and gene rearrangements as well as karyotypic
instability leading to aneuploidy and structural chromosom-
Figure 2
Pseudo-diploid karyotype of immortal human skin keratinocytes.
Spontaneous immortalization of the HaCaT skin keratinocytes correlated
with telomerase upregulation (Harle-Bachor and Boukamp, 1996) as well
as expression of distinct chromosomal changes, t(1;18), t(3q;4q), del(4q),
del(6p), and i(9q), as demonstrated by multicolor fluorescence in situ
hybridization (m-FISH). These marker chromosomes were also main-
tained stable during continuous passaging of the cells.
2Boukamp and Popp, unpublished observations.
3Moshir et al, in revision.
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al aberrations (for a review, see Mai and Mushinski, 2003).
The most intriguing features of c-Myc-induced alterations
are their reversibility. Using inducible systems, genomic in-
stability proved to be transient upon a single induction of c-
Myc in vitro and in vivo (Mai et al, 1996; Felsher and Bishop,
1999). Continued c-Myc activation, on the other hand, was
described to be accompanied by aneuploidy and structural
chromosomal changes such as extra-chromosomal ele-
ments and chromosomal breakage but also centromere–
telomere fusions. (Kuschak et al, 1999).
Telomeric Aggregates an Additional
Mechanism of Telomere-Dependent
Genomic Instability
We have recently started to study the telomere distribution
in the 3D nucleus by using 3D fixation, deconvolution mi-
croscopy, and reconstruction of the 3D structure by Amira
software (Indeed-Visual Concepts GmbH, Berlin, Germany).
This method allowed to determine that the telomere organ-
ization is cell cycle dependent, with assembly of the telo-
meres in a highly defined position during the G2 phase,
termed a telomeric disc (Chuang et al, 2004). In some tumor
cells, this organization was distorted due to the formation of
telomeric aggregates (TA). These TA, which could be of dif-
ferent size and number, were found to be present in all
tumor cells with known dysregulated c-Myc. In addition,
when comparing HaCaT cells and HaCaT cells constitutively
expressing the c-myc gene (HaCaT-myc), we could further
show that TA were present in the HaCaT-myc cells also
during the different phases of mitosis (Ermler et al, 2004).
This suggests that these aggregated telomeres are now
segregated as a group during mitosis (Fig 3). Depending on
the chromosome distribution within the TA, they are likely to
cause an uneven chromosome distribution during mitosis,
leading to gain of chromosome(s) in one and loss in the
other daughter cell. Thus, TA are likely to contribute to
aneuploidy.
Most recent studies further suggest that in addition to
numerical abnormalities, TA also contribute to structural
chromosomal aberrations. In fact, we have evidence that TA
formation is also of consequence for the chromosome in-
volved in the TA. By causing an overlap of chromosomal
territories upon TA induction, different chromosomes now
come into such close vicinity that translocations between
parts of different chromosomes can occur (Louis et al,
2005). Different from uncapping of the telomeres, which can
also be experimentally induced in long telomeres by elim-
inating TRF2 (van Steensel et al, 1998), we have no evi-
dence so far that TRF2 is involved in TA formation (Ermler
et al, 2004). One major function of TRF2 is to stabilize the 30
overhang, and with this, to protect the chromosomes from
end-to-end fusions. Correspondingly, when TRF2 was in-
hibited, a high percentage of the telomeres were fused, re-
sulting in dicentric chromosomes and chromatid dicentrics
(van Steensel et al, 1998). Although the level of TRF2 was
reduced to only 50% in HaCaT-myc cells that contained TA
in 460% of the nuclei, double-labeling studies of telomeric
DNA and TRF2 protein unequivocally demonstrate co-lo-
calization of TRF2 on all telomeres including the TA (Ermler
et al, 2004). Taken together, our findings are in support of
the hypothesis that TA formation is a length-independent
mechanism of telomere-dependent chromosomal instability
by which aneuploidy as well as structural chromosomal
aberrations (translocation chromosomes) can be generated.
Most importantly, TA formation may follow transfection of
certain genes, such as the c-myc oncogene, suggesting
that TA-dependent genomic instability can occur de novo in
tumor cells at any stage of carcinogenesis and thereby al-
low these cells to develop genetically divergent subpopulat-
ions—a hallmark of tumor development and progression.
Conclusion
Telomeres are likely to be involved in genomic instability by
a number of means. On the one hand, progressive telomere
shortening and the eventual critical short length are impli-
cated in uncapping of the telomeres. This is thought to
be causal for end-to-end fusions, leading to BFB cycles,
characterized by chromosome breakage, loss or amplifica-
tion of parts of the chromosome, and rejoining with other
chromosomes, i.e., generation of structural chromosomal
aberrations. On the other hand, telomeres can also form
aggregates that in turn cluster their respective chro-
mosomes, and may thereby favor uneven chromosome
distribution during mitosis with loss or gain of entire chro-
mosomes as well as inappropriate proximity of the chro-
mosome, allowing exchange of chromosomal material
Figure3
Telomere aggregates contribute to genomic instability. (A) Three-
dimensional (3D) distribution of chromosomes and telomeres during
anaphase of HaCaT cells showing a normal chromosome (in blue) and
telomere (in red) distribution. (B) Telomeres in yellow (3D) are shown on
the projected anaphase chromosomes (two-dimensional). Note the
telomeric aggregate (marked by arrowhead) and the connected chro-
mosomes forming an anaphase bridge (marked by arrow). (C) 3D dis-
tribution of chromosomes (in blue) and telomeres (in red) in a cell with
an anaphase bridge. Also note the extra chromosome that will be lost
during mitosis and is likely to give rise to extra-chromosomal DNA
(micronucleus) in one of the daughter cells. (D) 3D distribution of telo-
meres and DNA in telophase. Note that a complete chromosome will
be lost.
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(structural aberrations). A better understanding of both
mechanisms of telomere-dependent genomic instability is
essential for designing specific drugs that are able to inter-
fere with these processes. At present, a first telomerase
inhibitor is in clinical trial aiming to stop tumor growth by
inhibiting telomerase and pushing the cells into a telomere
loss-dependent senescence or apoptosis. Alternatively, or
in addition, there is a need to fight telomere-dependent
genomic instability in order to hinder the development of
genetically divergent subpopulations, i.e., to hinder tumor
heterogeneity.
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